Myelodysplastic Syndromes, Version 2.2015: Featured Updates to the NCCN Guidelines

The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a highly variable disease course that depends largely on risk factors. Risk evaluation is therefore a critical component of decision-making in the treatment of MDS. The development of new...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Natl Compr Canc Netw
Egile Nagusiak: Greenberg, Peter L., Stone, Richard M., Bejar, Rafael, Bennett, John M., Bloomfield, Clara D., Borate, Uma, De Castro, Carlos M., Deeg, H. Joachim, DeZern, Amy E., Fathi, Amir T., Frankfurt, Olga, Gaensler, Karin, Garcia-Manero, Guillermo, Griffiths, Elizabeth A., Head, David, Klimek, Virginia, Komrokji, Rami, Kujawski, Lisa A., Maness, Lori J., O’Donnell, Margaret R., Pollyea, Daniel A., Scott, Bart, Shami, Paul J., Stein, Brady L., Westervelt, Peter, Wheeler, Benton, Shead, Dorothy A., Smith, Courtney
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696005/
https://ncbi.nlm.nih.gov/pubmed/25736003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak